跳至主要内容
临床试验/JPRN-jRCT1080222139
JPRN-jRCT1080222139未知Unknown

Post-marketing surveillance of donepezil hydrochloride -Investigation of the safety and effectiveness of combination therapy of donepezil hydrochloride and memantine hydrochloride in patients with Alzheimer's Disease (Study ART07T)

Eisai Co., Ltd.0 个研究点目标入组 5,000 人开始时间: 2013年7月9日最近更新:
适应症

试验速览

阶段
Unknown
入组人数
5,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Patients diagnosed as Alzheimer's Disease who are to be administered both donepezil hydrochloride and memantine hydrochloride for the first time

排除标准

  • Patients with a history of hypersensitivity to any ingredients of Aricept or piperidine derivatives.

研究者

相似试验